3 assets in Inherited Blood Coagulation Disorder

Therapeutic assets addressing Inherited Blood Coagulation Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Turoctocog Alfa Inherited Blood Coagulation Disorder	Novo Nordisk A/S	P4	A (85)
Human Antihemophilic Factor/Von Willebrand Factor Complex Inherited Blood Coagulation Disorder	Assiut University	P4	BB (69)